In AD, TDP‐43 often appears as a secondary co‐pathology, and its aggregation is linked to soluble amyloid oligomers that may promote TDP‐43 aggregation through cross‐seeding mechanisms.125. This evidence concerns the gene TARDBP and Alzheimer disease.